Sterinova's Québec pharmaceutical facility launched with $70 mln
Biologic products company Sterinova Inc has opened its plant in Saint-Hyacinthe, Québec. The launch was made possible by about $70 million in funding from a group of Québec investors. They include the Fonds de solidarité FTQ, Fonds Manufacturier Québécois, Saint-Hyacinthe Technopole, Desjardins, Investissement Québec and Canada Economic Development for Quebec Regions (CED). Established in 2012, Sterinova specializes in the development and manufacture of sterile, ready-to-use injectable products for domestic and international markets.
14 October 2016•5 mins read
